この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Tomas B.に依頼
Belgium
Senior Biotech Consultant | Viral Vectors, RNA Therapeutics & Translational R&D Expert
プロフィール概要
専門分野
サービス
Writing
Technical Writing,
Business & Legal Writing,
Copywriting,
General Proofreading & Editing
Research
Feasibility Study,
Technology Scouting,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Business Strategy Consulting,
Go-to-Market Strategy Consulting,
Scientific and Technical Consulting
Data & AI
Statistical Analysis,
Data Visualization,
Text Mining & Analytics,
Data Insights
Product Development
Formulation,
Product Validation,
Concept Development,
Prototyping
職務経験
Biotech Consultant and Editor
TBos Consulting
5月 2025 - 現在
Founder / CSO
Questa Bio SRL
8月 2024 - 4月 2025
Founder / CEO
Sendai Therapeutix
5月 2019 - 7月 2024
Senior Research Manager
Glycostem
5月 2018 - 4月 2019
学歴
Postdoc
UC San Diego
9月 2012 - 12月 2017
Postdoc
Salk Institute for Biological Studies
10月 2011 - 8月 2012
Ph.D. in Medical Sciences
Vrije Universiteit Brussel
10月 2004 - 12月 2010
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
Tomas Bos, Ian J. Huggins, Olivia Gaylord, Christina Jessen, Brianna Lonquich, Angeline Puranen, Jenna Richter, Charlotte Rossdam, David Brafman, Terry Gaasterland, et al. (2017). The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells . Nature Communications.
Ranjan Batra, Thomas J Stark, Alex E. Clark, Jean-Philippe Belzile, Emily C Wheeler, Brian A Yee, Hui Huang, Chelsea Gelboin-Burkhart, Stephanie C Huelga, Stefan Aigner, et al. (2016). RNA-binding protein CPEB1 remodels host and viral RNA landscapes . Nature Structural & Molecular Biology.
Lode RY Goethals, Tomas J Bos, Luc Baeyens, Frank De Geeter, Nick Devoogdt, Tony Lahoutte (2014). Camelid reporter gene imaging: a generic method for in vivo cell tracking . EJNMMI Research.
Tomas Bos, Perpetua U. Emeagi, Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout, Anje Cauwels, Iain A. McNeish, Carlo Heirman, Kris Thielemans, Joeri L. Aerts, et al. (2012). Proinflammatory Characteristics of SMAC/DIABLO-Induced Cell Death in Antitumor Therapy . Cancer Research.
Marleen Keyaerts, Isabel Remory, Vicky Caveliers, Karine Breckpot, Tomas J. Bos, Jan Poelaert, Axel Bossuyt, Tony Lahoutte (2012). Inhibition of Firefly Luciferase by General Anesthetics: Effect on In Vitro and In Vivo Bioluminescence Imaging . PLoS ONE.
Petr Dmitriev, Andrei Petrov, Eugenie Ansseau, Luiza Stankevicins, Sébastien Charron, Elena Kim, Tomas Jan Bos, Thomas Robert, Ahmed Turki, Frédérique Coppée, et al. (2011). The Krüppel-like Factor 15 as a Molecular Link between Myogenic Factors and a Chromosome 4q Transcriptional Enhancer Implicated in Facioscapulohumeral Dystrophy . Journal of Biological Chemistry.
Tomas J. Bos, Elke De Bruyne, Sandra Van Lint, Carlo Heirman, Karin Vanderkerken (2010). Large double copy vectors are functional but show a size-dependent decline in transduction efficiency . Journal of Biotechnology.
Tomas J. Bos, Elke De Bruyne, Sandra Van Lint, Carlo Heirman, Karin Vanderkerken (2010). Large double copy vectors are functional but show a size-dependent decline in transduction efficiency . Journal of Biotechnology.
Elke De Bruyne, Tomas J. Bos, Frans Schuit, Els Van Valckenborgh, Eline Menu, Lieven Thorrez, Peter Atadja, Helena Jernberg-Wiklund, Karin Vanderkerken (2010). IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms . Blood.
J. Caers, D. Hose, I. Kuipers, T. J. Bos, E. Van Valckenborgh, E. Menu, E. De Bruyne, H. Goldschmidt, B. Van Camp, B. Klein, et al. (2010). Thymosin 4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma . Haematologica.
Tomas Bos, Elke De Bruyne, Carlo Heirman, Karin Vanderkerken (2009). In Search of the Most Suitable Lentiviral shRNA System . Current Gene Therapy.
Tomas Bos, Luc Baeyens, Stefan Bonné, Ilse Rooman, Cindy Peleman, Tony Lahoutte, Michael German, Harry Heimberg, Luc Bouwens (2009). Notch Signaling as Gatekeeper of Rat Acinar-to-β-Cell Conversion in Vitro . Gastroenterology.
Aude Bonehill, Sandra Tuyaerts, An MT Van Nuffel, Carlo Heirman, Tomas J Bos, Karel Fostier, Bart Neyns, Kris Thielemans (2008). Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA . Molecular Therapy.
Elke De Bruyne, Tomas Jan Bos, Kewal Asosingh, Isabelle Vande Broek, Eline Menu, Els Van Valckenborgh, Peter Atadja, Valérie Coiteux, Xavier Leleu, Kris Thielemans, et al. (2008). Epigenetic Silencing of the Tetraspanin CD9 during Disease Progression in Multiple Myeloma Cells and Correlation with Survival . Clinical Cancer Research.
Marleen Keyaerts, Jacob Verschueren, Tomas J. Bos, Lea Olive Tchouate-Gainkam, Cindy Peleman, Karine Breckpot, Chris Vanhove, Vicky Caveliers, Axel Bossuyt, Tony Lahoutte (2008). Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of d-luciferin: effect on intensity, time kinetics and repeatability of photon emission . European Journal of Nuclear Medicine and Molecular Imaging.
Tomas Bos, Elke De Bruyne, Sarah Deleu, Peter Atadja, Eline Menu, Els Van Valckenborgh, Ben Van Camp, Karin Vanderkerken (2007). Regulation of Bim Expression by IGF-1 in the 5T33MM Murine Model for Multiple Myeloma . Blood.
BOOK CHAPTER
Tomas J. Bos, Julia K. Nussbacher, Stefan Aigner, Gene W. Yeo (2016). Tethered Function Assays as Tools to Elucidate the Molecular Roles of RNA-Binding Proteins . Advances in Experimental Medicine and Biology.